HEALTH CARE COST AVOIDANCE DUE TO INSULIN GLARGINE FOR TYPE 2 DIABETIC PATIENTS IN HONG KONG AS COMPARED TO NPH INSULIN

被引：0
|
作者：
Lee, K. K. [1 ]
Wu, D. B. C. [2 ]
机构：
[1] Monash Univ, Selangor, Malaysia
[2] Monash Univ, Kuala Lumpur, Malaysia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.735
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A451 / A451
页数：1
相关论文
共 50 条
  • [21] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
    Kodela, B.
    Petrovic, J.
    Velickovic-Radovanovic, R.
    Lilic, R.
    Radenkovic, S.
    Dedovic, I
    VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
  • [22] Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus
    Gupta, K. S.
    Gupta, U.
    VALUE IN HEALTH, 2007, 10 (03) : A70 - A70
  • [23] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    VALUE IN HEALTH, 2008, 11 (06) : A514 - A514
  • [24] Comparison of the subcutaneous absorption of insulin glargine (Lantus®) and NPH insulin in patients with type 2 diabetes
    Luzio, SD
    Beck, P
    Owens, DR
    HORMONE AND METABOLIC RESEARCH, 2003, 35 (07) : 434 - 438
  • [25] Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy
    Yokoyama, Hiroki
    Tada, Junko
    Kamikawa, Futayo
    Kanno, Sakiko
    Yokota, Yuki
    Kuramitsu, Masae
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 73 (01) : 35 - 40
  • [26] Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients
    Pfeiffer, C
    Winkler, F
    Luger, A
    Pieber, T
    Saudek, F
    Skrha, J
    Hermansen, K
    Lervang, HH
    Nistrup-Holmegaard, S
    Bergkulla, S
    Lembcke, HJ
    Schulze, J
    Petersen, KG
    Haslbeck, M
    Jonker, JJC
    Vaaler, S
    Rolstad, OJ
    Distiller, LA
    Robertson, LI
    Omar, MAK
    Wing, J
    Arner, P
    Arnqvist, H
    Lager, I
    Lennerhagen, P
    Borthwick, LJ
    Hattersley, A
    Owens, DR
    Matthews, DR
    Nattrass, M
    DIABETIC MEDICINE, 2003, 20 (07) : 545 - 551
  • [27] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
    Home, PD
    Rosskamp, R
    Forjanic-Klapproth, J
    Dressler, A
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
  • [28] Cost Savings in Type 2 Diabetes with Insulin Glargine Compared with Insulin Detemir in the UK
    Evans, Marc
    Owens, David
    Carroll, Dawn
    Keech, Martin
    DIABETES, 2009, 58 : A517 - A517
  • [29] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
    McEwan, Phil
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    Currie, Craig J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
  • [30] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    DIABETES CARE, 2005, 28 (04) : 950 - 955
12345